Shirun Chu

ORCID: 0000-0003-0713-3562
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Bioactive Compounds and Antitumor Agents
  • Computational Drug Discovery Methods
  • Bone Tissue Engineering Materials
  • Orthopaedic implants and arthroplasty
  • Synthesis and biological activity
  • Graphene and Nanomaterials Applications

Southwest Jiaotong University
2025

Abstract Background Ru-kang-yin (RKY), a traditional Chinese herbal prescription, has been clinically used as adjuvant therapy for breast cancer via inhibiting cell invasion, proliferation, and promoting apoptosis. However, its anti-breast bio-active ingredients possible mechanisms are still unclear. In the present study, hub compounds underlying of RKY in treatment were systematically elucidated by approach network pharmacology. Methods By using pharmacology approach, total 53 nonredundant...

10.21203/rs.3.rs-69347/v1 preprint EN cc-by Research Square (Research Square) 2020-09-17
Coming Soon ...